國家衛生研究院 NHRI:Item 3990099045/8679

NHRI > National Institute of Infectious Diseases and Vaccinology > Shu-Chen Kuo > Periodical Articles > Item 3990099045/8679

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/8679

Title:	Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure
Authors:	Liou, BH;Lee, YT;Kuo, SC;Liu, PY;Fung, CP
Contributors:	Division of Infectious Diseases
Abstract:	We described the clinical outcome of 17 patients with secondary Acinetobacter bacteremia, whose isolates had a tigecycline minimal inhibitory concentration of </= 2mg/L and that received tigecycline within 2 days of bacteremia onset. Fourteen-day mortality rate of tigecycline cohort was 41.2% (7/17), which was significantly higher than those receiving other appropriate antimicrobial agents (13.8%, 9/65, P=0.018). However, the percentages of end-stage renal disease and congestive heart failure were higher in the tigecycline cohort. Efficacy of tigecycline was contingent upon the illness severity and bacterial species. Tigecycline should be applied cautiously for treatment of Acinetobacter bacteremia.
Date:	2015-06
Relation:	Antimicrobial Agents and Chemotherapy. 2015 Jun;59(6):3637-3640.
Link to:	http://dx.doi.org/10.1128/aac.04987-14
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0066-4804&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000358623200093
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84929648571
Appears in Collections:	[Shu-Chen Kuo] Periodical Articles

Files in This Item:

File	Description	Size	Format
PUB25824230.pdf		152Kb	Adobe PDF	326	View/Open